GST Reform: NPPA Directs Drug Makers to Pass on Benefits Through Revised MRPs from Sept 22



Quick Summary
The National Pharmaceutical Pricing Authority (NPPA) has instructed drug manufacturers and marketing companies to reduce the Maximum Retail Price (MRP) of medicines and medical devices from September 22, 2025. This change is a result of the recent GST rate rationalisation. Companies must pass on the benefit of lower GST rates to consumers and update their price lists accordingly. While re-labelling existing stock is not mandatory, manufacturers are encouraged to communicate the revised prices widely.

The National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals Fertilizers, Department of Pharmaceuticals, has issued an Office Memorandum (F. No. 12(24)/2021/1DP/NFPA/Div.II(Vol.II)-Part(1)) mandating the implementation of revised Maximum Retail Prices (MRPs) for medicines, formulations, and medical devices, effective from 22nd September 2025, in light of the recent Goods and Services Tax (GST) rate rationalisation announced during the 56th GST Council meeting. Key Hi
Daily Limit Reached

You have reached your daily limit of 2 Free News

Subscribe to CCI PRO for unlimited access

Why Upgrade to CCI PRO?
  • No Ads
  • WhatsApp Community
  • Daily E-Newsletter
  • Unlimited News Access
  • Profile Visitors
  • Link Social Profiles
  • Featured Job Posts
  • Pro Badge
  • Expert GST Guidance
  • Unlimited Forum Replies
  • Download Content in PDF
1 Year PLAN
1999
(Excl. of GST ₹359)

BEST VALUE
2 Years PLAN
3499
(Excl. of GST ₹629)

3 Months PLAN
999
(Excl. of GST ₹179)

View all CCI PRO benefits

Already a PRO member? Login here for an ad-free experience.

FAQ :

The NPPA has directed drug manufacturers and marketing companies to pass on the benefits of reduced GST rates to consumers by revising the Maximum Retail Prices (MRPs) of medicines and medical devices.

The revised MRPs, reflecting the reduced GST rates, will be effective from 22nd September 2025.

No, it is not mandatory to re-label or re-sticker products already in the market before 22nd September 2025, provided the revised MRPs are publicly communicated.

Manufacturers are directed to use all communication channels, including print, electronic, and social media, to inform dealers, retailers, and consumers about the revised GST rates and MRPs.

Industry associations are encouraged to release advertisements in leading national and vernacular newspapers to inform dealers and retailers about the revised GST rates and ensure compliance.

Yes, manufacturers can opt for phased re-labelling or re-stickering of stock, provided it does not lead to shortages of drugs or medical devices.




News posted by

Finance news reporter covering taxation, GST, income tax, business compliance, and economy updates. I simplify complex financial topics into easy-to-understand articles for professionals, taxpayers, and business owners on leading finance and tax platforms.

Comments :


More »


Popular News





CCI Pro



Company
Featured 21 September 2026
Consultant - Reporting

Finrep Advisors LLP

Mumbai

CA

View Details
Company
18 September 2026
Accounts & Finance Specialist

ULTRA CHEMICAL WORKS

Thane

CA Final

View Details
Company
16 September 2026
Internal Audit - Team Lead

Consulting & Beyond

Chennai

CA

View Details
Company
19 September 2026
CA/Semi-CA/BCom

Pravin Sarvaiya

Mumbai

CA Inter

View Details
Company
Featured 12 September 2026
Assistant Manager - Finance & Compliance

Naveen Fintech Pvt Ltd

Kolkata

CA Inter

View Details
Company
ARTICLESHIP 26 August 2026
Article Assistant

ANIVESH CONSULTANTS LLP

Gurgaon

CA Inter

View Details
Company
08 September 2026
Audit Executive

Thammana & Associates

Srikakulam

B.Com

View Details
Company
ARTICLESHIP 24 August 2026
Chartered Accountant Articles

Rohit KC Jain & Co

New Delhi

CA Inter

View Details